Nuveen’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.2K Buy
+2,913
New +$17.5K ﹤0.01% 4351
2025
Q2
– Sell
-21,647
Closed -$116K – 3415
2025
Q1
$116K Hold
21,647
– – ﹤0.01% 3202
2024
Q4
$161K Buy
21,647
+8,037
+59% +$66.1K ﹤0.01% 3238
2024
Q3
$123K Hold
13,610
– – ﹤0.01% 3295
2024
Q2
$145K Buy
+13,610
New +$145K ﹤0.01% 3274
2021
Q2
– Sell
-14,536
Closed -$120K – 3535
2021
Q1
$120K Hold
14,536
– – ﹤0.01% 3273
2020
Q4
$94K Hold
14,536
– – ﹤0.01% 3237
2020
Q3
$86K Hold
14,536
– – ﹤0.01% 3224
2020
Q2
$102K Buy
+14,536
New +$106K ﹤0.01% 3159

Other funds holding ULBI

Nuveen's ULBI Position: Q3 2026 in Review

Nuveen opened a new position in Ultralife (ULBI) in Q3 2026: 2,913 shares worth $26.2K. The stake represents ﹤0.01% of the portfolio and ranks #4351 among its holdings. This is a return to the name: Nuveen previously reported a position in ULBI as recently as Q1 2025.

Nuveen first reported a position in ULBI in Q2 2020 and has held it in 9 quarters since. The position peaked at $161K in Q4 2024. 17 funds tracked by Wall St. Rank hold ULBI as of Q3 2026.

  • Nuveen held 2,913 shares of Ultralife worth $26.2K as of Q3 2026.
  • Ultralife was a new Nuveen position in Q3 2026.
  • Ultralife made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4351 holding.
  • Nuveen first reported a position in Ultralife in Q2 2020 and has held it in 9 quarters since.
  • Nuveen's Ultralife position peaked at $161K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Ultralife as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.